M.D. Rebecca Taub

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Mardi Dier, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by M.D. Rebecca Taub:

Company Role Class Num Shares Value Price $ Report Date Ownership
MADRIGAL PHARMACEUTICALS, INC. Director Common Stock 655,540 $381,747,098 $582.34 26 Jan 2026 By SQN LLC
MADRIGAL PHARMACEUTICALS, INC. Director Common Stock 452,704 $222,920,503 $492.42 26 Jan 2026 Direct
MADRIGAL PHARMACEUTICALS, INC. Director Stock Option (Right to Buy) 0 09 Jan 2026 Direct

Insider Reports Filed by M.D. Rebecca Taub

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MDGL MADRIGAL PHARMACEUTICALS, INC. 26 Jan 2026 1 -$318,596 4 Director 26 Jan 2026, 17:05
MDGL MADRIGAL PHARMACEUTICALS, INC. 20 Jan 2026 1 -$1,098,343 4 Director 20 Jan 2026, 17:46
MDGL MADRIGAL PHARMACEUTICALS, INC. 09 Jan 2026 4 -$128,288 4 Director 13 Jan 2026, 16:38
MDGL MADRIGAL PHARMACEUTICALS, INC. 09 Jan 2026 30 -$9,326,434 4 Director 13 Jan 2026, 16:34
MDGL MADRIGAL PHARMACEUTICALS, INC. 10 Dec 2025 12 -$10,002,903 4 Director 12 Dec 2025, 16:35
MDGL MADRIGAL PHARMACEUTICALS, INC. 11 Aug 2025 16 -$16,069,956 4 Director 13 Aug 2025, 17:33
MDGL MADRIGAL PHARMACEUTICALS, INC. 18 Jul 2025 3 -$340,555 4 Director 22 Jul 2025, 17:08
MDGL MADRIGAL PHARMACEUTICALS, INC. 16 Jul 2025 13 -$10,003,094 4 Director 18 Jul 2025, 16:11
MDGL MADRIGAL PHARMACEUTICALS, INC. 05 Mar 2025 2 $0 4 Pres., R&D, and CMO, Director 07 Mar 2025, 17:00
MDGL MADRIGAL PHARMACEUTICALS, INC. 24 Jan 2025 1 -$217,236 4 Pres., R&D, and CMO, Director 27 Jan 2025, 17:07
MDGL MADRIGAL PHARMACEUTICALS, INC. 17 Jan 2025 1 -$461,789 4 Pres., R&D, and CMO, Director 17 Jan 2025, 19:05
MDGL MADRIGAL PHARMACEUTICALS, INC. 08 Apr 2024 8 -$632,969 4 Pres., R&D, and CMO, Director 10 Apr 2024, 20:53
MDGL MADRIGAL PHARMACEUTICALS, INC. 03 Apr 2024 25 -$17,324,347 4 Pres., R&D, and CMO, Director 05 Apr 2024, 20:50
MDGL MADRIGAL PHARMACEUTICALS, INC. 23 Jan 2024 3 $0 4 Pres., R&D, and CMO, Director 25 Jan 2024, 17:54
MDGL MADRIGAL PHARMACEUTICALS, INC. 16 Jan 2024 1 -$377,100 4 Pres., R&D, and CMO, Director 18 Jan 2024, 13:46
MDGL MADRIGAL PHARMACEUTICALS, INC. 16 Jan 2023 1 $0 4 Pres., R&D, and CMO, Director 18 Jan 2023, 19:00
BCTX BriaCell Therapeutics Corp. 01 Aug 2022 0 $0 3 Director 01 Aug 2022, 16:10
MDGL MADRIGAL PHARMACEUTICALS, INC. 22 Feb 2022 1 $0 4 Chief Medical Officer, President, R&D ** As attorney-in-fact for Reporting Person, Director 24 Feb 2022, 19:12